医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Toshiba Introduces Latest Additions to ApP Lite(TM) Family for IoT Solutions

2015年02月24日 PM03:19
このエントリーをはてなブックマークに追加


 

TOKYO

Toshiba Corporation (TOKYO:6502) today announced the launch of “TZ1031MBG” and “TZ1011MBG” application processors for wearable devices, as the latest additions to its ApP Lite™ family’s TZ1000 series, to provide solutions for the Internet of Things (IoT).

Toshiba: new application processor "TZ1011MBG" for wearable devices (Photo: Business Wire)

Toshiba: new application processor “TZ1011MBG” for wearable devices (Photo: Business Wire)

Sample shipments of the “TZ1031MBG” will start this month and mass production is scheduled to start in May. For the TZ1011MBG, these dates are this month and June respectively. Both ICs will be showcased at “Embedded World 2015”, to be held from February 24 in Nuremberg, Germany.

There has been an explosion of interest in services that monitor the duration and level of physical activity to promote exercise, improve nutrition and help prevent diseases related to lifestyle. This has increased the demand for wearable devices.

Last November, Toshiba launched the “TZ1001MBG”application processor, a single package that integrates sensors for data collecting, a processor for data processing, flash memory for data storage, and a Bluetooth® Low Energy controller for data communication. Building on this, the new application processors expand sensing functionalities by adding a gyroscope to the “TZ1031MBG” and a gyroscope and magnetometer to the “TZ1011MBG”.

The high level integration of the new application processors makes it possible to realize wearable devices without any other components. It also contributes to a smaller form factor, which enables wearable devices to be reduced in size.

The new processors are expressly designed for low power performance, essential for securing a longer battery life for wearable devices.

Toshiba is expanding its line-up of systematic solutions for the TZ1000 series by developing software algorithms that can be applied to measuring weak biomedical signals, such as pulse and ECG. Meanwhile, Toshiba is providing an evaluation environment for developers to shorten the time to market for products integrating its application processors.

Embedded world 2015
https://www.embedded-world.de/en/

Key Features

  • Integrates a wireless communication function, sensors, a memory and a processor in one package
    Functions necessary for wearable devices are integrated into a single package, contributing to small system design.
  • Embedded ARM® Cortex®-M4F processor
    High performance ARM Cortex-M4F with DSP and floating point processing unit allows combination of data from multiple sensors, both internal and external, to improve accuracy (sensor fusion).
  • High resolution ADCs
    The products integrate a 24-bit high resolution ΔΣADC with high speed switches connected to three input channels, so as to be capable of measuring weak biomedical signals, such as the pulse and the heart’s electrical activity.
  • Integrates Bluetooth® wireless communication function
    Integration of Bluetooth® Low Energy controller and RF circuit allows transfer of raw and processed data to external equipment, such as smartphones and tablets.

Applications

Wearable devices, such as activity monitors, smart watches, bracelet and glasses-type devices.

 

Product Lineup

Product Name   TZ1001MBG   TZ1011MBG   TZ1021MBG   TZ1031MBG
CPU ARM Cortex-M4F 48MHz
Flash Memory 8Mbit
Sensor   Accelerometer Y Y Y
Gyroscope Y Y
Magnetometer Y
Bluetooth Low Energy Y Y Y
24bit delta-sigma ADC Y
I/O USB, SPI, I2C, UART
Dimensions

W x D x H mm

6.70 x 8.00 x 1.59 8.50 x 9.80 x 1.60 6.70 x 4.00 x 1.00 8.50 x 9.80 x 1.60
Engineering Sample Now Feb.2015 Now Feb.2015
Mass Production   Now   Jun.2015   Mar.2015   May.2015

* Bluetooth® is a registered trademark owned by Bluetooth SIG, Inc. and any use of such mark by Toshiba is under license.
* ARM and Cortex are registered trademarks of ARM Limited (or its subsidiaries) in the EU and/or elsewhere.
* ApP Lite is a trademark of Toshiba Corporation.
* All other trademarks and trade names are properties of their respective owners.

For further information about this product, please visit:
http://toshiba.semicon-storage.com/ap-en/product/assp/applite/tz1000.html

Customer Inquiries:
Logic LSI Sales & Marketing Group
Tel: +81-44-548-2110
http://toshiba.semicon-storage.com/ap-en/contact.html

Information in this document, including product prices and specifications, content of services and contact information, is current on the date of the announcement but is subject to change without prior notice.

About Toshiba

Toshiba Corporation, a Fortune Global 500 company, channels world-class capabilities in advanced electronic and electrical product and systems into five strategic business domains: Energy & Infrastructure, Community Solutions, Healthcare Systems & Services, Electronic Devices & Components, and Lifestyles Products & Services. Guided by the principles of The Basic Commitment of the Toshiba Group, “Committed to People, Committed to the Future”, Toshiba promotes global operations towards securing “Growth Through Creativity and Innovation”, and is contributing to the achievement of a world in which people everywhere live in safe, secure and comfortable society.

Founded in Tokyo in 1875, today’s Toshiba is at the heart of a global network of over 590 consolidated companies employing over 200,000 people worldwide, with annual sales surpassing 6.5 trillion yen (US$63 billion).
To find out more about Toshiba, visit www.toshiba.co.jp/index.htm

Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20150223006677/en/

CONTACT

Media Inquiries:
Toshiba Corporation
Semiconductor & Storage
Products Company
Chiaki Nagasawa, +81-3-3457-4963
semicon-NR-mailbox@ml.toshiba.co.jp

同じカテゴリーの記事 

  • La Jolla Institute for Immunology and RevolKa started a Research Collaboration
  • U.S. FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease
  • ESCMID Global 2024: Shionogi presents real-world data demonstrating efficacy of Fetcroja® / Fetroja® (cefiderocol) in critically ill patients with certain difficult-to-treat bacterial infections
  • Renesas’ New FemtoClock™ 3 Timing Solution Delivers Industry’s Lowest Power and Leading Jitter Performance of 25fs-rms
  • 成人向け予防接種プログラムは初期投資の19倍もの社会経済的価値をもたらすとの新レポートを発表